Central Serous Chorioretinopathy (CSC) Unknown Status Phase 2 Trials for Methotrexate (DB00563)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01633983Methotrexate for Central Serous Chorioretinopathy Treatment TrialTreatment